Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen

1. Rizzardini, G.
2. Gori, A.
3. Miralles, C.
4. Olalla, J.
5. Molina, J.-M.
6. Raffi, F.
7. Kumar, P.
8. Antinori, A.
9. Ramgopal, M.
10. Stellbrink, H.-J.
11. Das, M.
12. Chu, H.
13. Ram, R.
14. Garner, W.
15. Shao, Y.
16. Chuck, S.K.
17. Piontkowsky, D.
18. Haubrich, R.H.